
Mark C. Hageman
Examiner (ID: 17308, Phone: (571)272-5547 , Office: P/3652 )
| Most Active Art Unit | 3652 |
| Art Unit(s) | 3653, 3619, 3652 |
| Total Applications | 977 |
| Issued Applications | 657 |
| Pending Applications | 91 |
| Abandoned Applications | 247 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12408411
[patent_doc_number] => 09969736
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-15
[patent_title] => Substituted xanthines and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 15/622838
[patent_app_country] => US
[patent_app_date] => 2017-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61159
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15622838
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/622838 | Substituted xanthines and methods of use thereof | Jun 13, 2017 | Issued |
Array
(
[id] => 16006761
[patent_doc_number] => 10674728
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-09
[patent_title] => Pesticidal compositions
[patent_app_type] => utility
[patent_app_number] => 16/309849
[patent_app_country] => US
[patent_app_date] => 2017-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8489
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16309849
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/309849 | Pesticidal compositions | Jun 5, 2017 | Issued |
Array
(
[id] => 13689515
[patent_doc_number] => 20170355712
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-14
[patent_title] => AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 15/601888
[patent_app_country] => US
[patent_app_date] => 2017-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 113788
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15601888
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/601888 | AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS | May 21, 2017 | Abandoned |
Array
(
[id] => 11956023
[patent_doc_number] => 20170260174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-14
[patent_title] => 'Benzene, Pyridine, and Pyridazine Derivatives'
[patent_app_type] => utility
[patent_app_number] => 15/601428
[patent_app_country] => US
[patent_app_date] => 2017-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51878
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15601428
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/601428 | Benzene, Pyridine, and Pyridazine Derivatives | May 21, 2017 | Abandoned |
Array
(
[id] => 12621459
[patent_doc_number] => 20180098983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-12
[patent_title] => CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 15/599378
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55620
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15599378
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/599378 | CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | May 17, 2017 | Abandoned |
Array
(
[id] => 12058568
[patent_doc_number] => 20170334913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'Methods Of Preparing Carbocyclic Nucleosides'
[patent_app_type] => utility
[patent_app_number] => 15/597872
[patent_app_country] => US
[patent_app_date] => 2017-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11876
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15597872
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/597872 | Methods Of Preparing Carbocyclic Nucleosides | May 16, 2017 | Abandoned |
Array
(
[id] => 12051163
[patent_doc_number] => 20170327508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'DEUTERATED HETEROARYL SULFONAMIDES AND THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 15/596278
[patent_app_country] => US
[patent_app_date] => 2017-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14235
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15596278
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/596278 | DEUTERATED HETEROARYL SULFONAMIDES AND THEIR USE | May 15, 2017 | Abandoned |
Array
(
[id] => 16770772
[patent_doc_number] => 10981860
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-20
[patent_title] => Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereof
[patent_app_type] => utility
[patent_app_number] => 16/099989
[patent_app_country] => US
[patent_app_date] => 2017-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 83842
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16099989
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/099989 | Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereof | May 10, 2017 | Issued |
Array
(
[id] => 12975562
[patent_doc_number] => 20170340604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => THERAPEUTIC COMPOUNDS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/592012
[patent_app_country] => US
[patent_app_date] => 2017-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48733
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15592012
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/592012 | Therapeutic compounds and uses thereof | May 9, 2017 | Issued |
Array
(
[id] => 12049801
[patent_doc_number] => 20170326146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'METHODS OF TREATING HEPATITIS B INFECTIONS AND RELATED DOSAGE REGIMES'
[patent_app_type] => utility
[patent_app_number] => 15/591340
[patent_app_country] => US
[patent_app_date] => 2017-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15483
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15591340
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/591340 | METHODS OF TREATING HEPATITIS B INFECTIONS AND RELATED DOSAGE REGIMES | May 9, 2017 | Abandoned |
Array
(
[id] => 11935079
[patent_doc_number] => 20170239227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'COMPOUNDS AND COMPOSITIONS FOR INDUCING CHONDROGENESIS'
[patent_app_type] => utility
[patent_app_number] => 15/587652
[patent_app_country] => US
[patent_app_date] => 2017-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42859
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15587652
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/587652 | Compounds and compositions for inducing chondrogenesis | May 4, 2017 | Issued |
Array
(
[id] => 15227537
[patent_doc_number] => 10501479
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-10
[patent_title] => Benzenesulfonyl-asymmetric ureas and medical uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/464430
[patent_app_country] => US
[patent_app_date] => 2017-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24618
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15464430
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/464430 | Benzenesulfonyl-asymmetric ureas and medical uses thereof | Mar 20, 2017 | Issued |
Array
(
[id] => 11963526
[patent_doc_number] => 20170267679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-21
[patent_title] => 'TRICYCLIC FUSED PYRIMIDINE COMPOUNDS AS INHIBITORS OF p97 COMPLEX'
[patent_app_type] => utility
[patent_app_number] => 15/458955
[patent_app_country] => US
[patent_app_date] => 2017-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53956
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15458955
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/458955 | TRICYCLIC FUSED PYRIMIDINE COMPOUNDS AS INHIBITORS OF p97 COMPLEX | Mar 13, 2017 | Abandoned |
Array
(
[id] => 11714781
[patent_doc_number] => 20170183279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'RESIST COMPOSITION, METHOD FOR FORMING RESIST PATTERN, POLYPHENOLIC COMPOUND FOR USE IN THE COMPOSITION, AND ALCOHOLIC COMPOUND THAT CAN BE DERIVED THEREFROM'
[patent_app_type] => utility
[patent_app_number] => 15/458229
[patent_app_country] => US
[patent_app_date] => 2017-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30937
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15458229
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/458229 | RESIST COMPOSITION, METHOD FOR FORMING RESIST PATTERN, POLYPHENOLIC COMPOUND FOR USE IN THE COMPOSITION, AND ALCOHOLIC COMPOUND THAT CAN BE DERIVED THEREFROM | Mar 13, 2017 | Abandoned |
Array
(
[id] => 16444853
[patent_doc_number] => 10836765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-17
[patent_title] => Process for the preparation of valacyclovir
[patent_app_type] => utility
[patent_app_number] => 16/081944
[patent_app_country] => US
[patent_app_date] => 2017-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2984
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16081944
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/081944 | Process for the preparation of valacyclovir | Feb 23, 2017 | Issued |
Array
(
[id] => 11743860
[patent_doc_number] => 20170197932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'NOVEL STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/429939
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 21739
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15429939
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/429939 | NOVEL STAT3 PATHWAY INHIBITORS AND CANCER STEM CELL INHIBITORS | Feb 9, 2017 | Abandoned |
Array
(
[id] => 13357223
[patent_doc_number] => 20180230151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-16
[patent_title] => PROCESS FOR THE PREPARATION OF TRIAZOLE AND SALT THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/429278
[patent_app_country] => US
[patent_app_date] => 2017-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3886
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15429278
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/429278 | Process for the preparation of triazole and salt thereof | Feb 9, 2017 | Issued |
Array
(
[id] => 11757401
[patent_doc_number] => 20170204269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'METHOD OF ISOLATING BLUE ANTHOCYANIN FRACTIONS'
[patent_app_type] => utility
[patent_app_number] => 15/426559
[patent_app_country] => US
[patent_app_date] => 2017-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 10943
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15426559
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/426559 | Method of isolating blue anthocyanin fractions | Feb 6, 2017 | Issued |
Array
(
[id] => 13901723
[patent_doc_number] => 20190040066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-07
[patent_title] => PROCESS FOR THE PREPARATION OF PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 16/075003
[patent_app_country] => US
[patent_app_date] => 2017-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16075003
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/075003 | PROCESS FOR THE PREPARATION OF PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR | Feb 2, 2017 | Abandoned |
Array
(
[id] => 11866135
[patent_doc_number] => 20170233419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-17
[patent_title] => 'Guanine Analogs as Telomerase Substrates and Telomere Length Affectors'
[patent_app_type] => utility
[patent_app_number] => 15/419559
[patent_app_country] => US
[patent_app_date] => 2017-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 44280
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15419559
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/419559 | Guanine analogs as telomerase substrates and telomere length affectors | Jan 29, 2017 | Issued |